The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Treatment of Multidrug‐Resistant Acinetobacter baumannii Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
Abstract
We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in 35 episodes of ventilator-associated pneumonia (VAP) due to multidrug-resistant Acinetobacter baumannii. Microbiological diagnosis was performed with use of quantitative culture. In 21 patients, the episodes were caused by a strain susceptible exclusively to colistin (the CO group) and were all treated with this antimicrobial intravenously. In 14 patients, the episodes were caused by strains that remained susceptible to imipenem and were treated with imipenem-cilastatin (the IM group). Acute Physiology and Chronic Health Evaluation II scores at the time of admission and Sequential Organ Failure Assessment scores at time of diagnosis were similar in both groups. VAP was considered clinically cured in 57% of cases in both groups. In-hospital mortality rates were 61.9% in the CO group and 64.2% in the IM group, and the VAP-related mortality rates were 38% and 35.7%, respectively. Four patients in the CO group and 6 in the IM group developed renal failure. Neurophysiological evaluation was performed during 12 episodes in the CO group, but it revealed no signs of neuromuscular blockade. Intravenous colistin appears to be a safe and effective alternative to imipenem for the management of VAP due to carbapenem-resistant strains of A. baumannii.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Fagon, J.-Y., Chastre, J., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,180
Alvarez-Lerma, F., & ICU-Acquired Pneumonia Study Group (1996) · Intensive Care Medicine · doi:10.1007/bf01712153 · Cited by 652
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
The Influence of Mini-BAL Cultures on Patient Outcomes
MD, M. H. K., & Ward, S. (1998) · Chest · doi:10.1378/chest.113.2.412 · Cited by 494
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
RELLO, J., GALLEGO, M., MARISCAL, D., SOÑORA, R., & VALLES, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467
Garnacho-Montero, J., Madrazo-Osuna, J., García-Garmendia, J., Ortiz-Leyba, C., Jiménez-Jiménez, F., Barrero-Almodóvar, A., Garnacho-Montero, M., & Moyano-Del-Estad, M. (2001) · Intensive Care Medicine · doi:10.1007/s001340101009 · Cited by 402
Self-citationThe Effect of Late-Onset Ventilator-Associated Pneumonia in Determining Patient Mortality
Kollef, M. H., Silver, P., Murphy, D. M., & Trovillion, E. (1995) · Chest · doi:10.1378/chest.108.6.1655 · Cited by 402
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Bercault, N., & Boulain, T. (2001) · Critical Care Medicine · doi:10.1097/00003246-200112000-00012 · Cited by 303
Ibrahim, E. H., Ward, S., Sherman, G., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.117.5.1434 · Cited by 284
Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients
Pittet, D., Thiévent, B., Wenzel, R. P., Li, N., Gurman, G., & Suter, P. M. (1993) · Intensive Care Medicine · doi:10.1007/bf01690546 · Cited by 190
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Wood, G. C., Hanes, S. D., Croce, M. A., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 157
Montero, A., Ariza, J., Corbella, X., Domenech, A., Cabellos, C., Ayats, J., Tubau, F., Ardanuy, C., & Gudiol, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1946-1952.2002 · Cited by 143
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Brun‐Buisson, C., Sollet, J.-P., Schweich, H., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516294 · Cited by 113
Rodríguez-Hernández, M. J., Pachón, J., Pichardo, C., et al. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.493 · Cited by 110
Wolff, M., Joly‐Guillou, M., Farinotti, R., & Carbon, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1406 · Cited by 85
Álvarez-Lerma, F., Insausti-Ordeñana, J., Jordà‐Marcos, R., et al. (2001) · Intensive Care Medicine · doi:10.1007/s001340000846 · Cited by 70
Torres, A. (2000) · Thorax · doi:10.1136/thorax.55.12.1033 · Cited by 69
Acinetobacter: Epidemiology and Control
Rahal, J. J., & Urban, C. M. (2001) · Perspectives on critical care infectious diseases · doi:10.1007/978-1-4615-0781-9_6 · Cited by 1
Cited by
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Metadata
- Authors
- Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05
- Volume
- 36
- Issue
- 9
- Pages
- 1111-1118
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2124996394
- Cited by
- 470
- References
- 28
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.